NanoSphere Health Sciences Inc.
NSHS
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -221.96% | 468.57% | 25.53% | 85.49% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 101.24% | -106.54% | -118.37% | -135.38% |
| Change in Net Operating Assets | 0.00% | 13.89% | 251.26% | -121.17% | -39.76% |
| Cash from Operations | 0.00% | 18.93% | 51.45% | -390.22% | -56.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | -43.93% | 1,170.00% | -107.58% | 266.67% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -43.93% | 1,170.00% | -107.58% | 266.67% |
| Foreign Exchange rate Adjustments | 0.00% | -6.37% | -68.47% | 293.13% | 39.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 0.00% | 62.50% | -169.57% | 1,250.00% |